Literature DB >> 3976221

Polyamines in clinical disorders.

D F Tierney, L J Marton, A D Hacker, N Lowe.   

Abstract

An edited summary of an Interdepartmental Conference arranged by the Department of Medicine of the UCLA School of Medicine, Los Angeles. The Director of Conferences is William M. Pardridge, MD, Associate Professor of Medicine.Polyamines, necessary for cell growth, influence many cell functions. As small polyvalent cations they can change the configuration of large polyvalent anions, such as DNA, and alter their sensitivity to other molecules including chemotherapeutic agents. By altering polyamine content in a cell, we can change its growth, its susceptibility to drugs and change other cellular functions. Malignant conditions, other proliferative diseases and infections are the most apparent clinical conditions likely to improve by depleting polyamines and suppressing cell growth. Proliferative disorders of the skin respond to many agents that suppress polyamine metabolism. Hyperoxia may suppress cell growth in the lung by suppressing polyamine metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976221      PMCID: PMC1305929     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  68 in total

Review 1.  Cytokinetics in diseases of epidermal hyperplasia.

Authors:  G D Weinstein; J L McCullough
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

2.  Pentose pathway and production of reduced nicotinamide adenine dinucleotide phosphate. A mechanism that may protect lungs from oxidants.

Authors:  D Tierney; L Ayers; S Herzog; J Yang
Journal:  Am Rev Respir Dis       Date:  1973-12

3.  The effect of spermine and oxidized spermine on the enzymic degradation of DNA.

Authors:  U Bachrach; G Eilon
Journal:  Biochim Biophys Acta       Date:  1969-04-22

4.  Superoxide dismutase and pulmonary oxygen toxicity.

Authors:  J D Crapo; D F Tierney
Journal:  Am J Physiol       Date:  1974-06

5.  A comparison between DNA synthesis and mitosis in uninvolved and involved psoriatic epidermis and normal epidermis.

Authors:  P Goodwin; S Hamilton; L Fry
Journal:  Br J Dermatol       Date:  1973-12       Impact factor: 9.302

Review 6.  Cellular mechanisms of oxygen toxicity.

Authors:  N Haugaard
Journal:  Physiol Rev       Date:  1968-04       Impact factor: 37.312

7.  Cell proliferation in lungs of mice exposed to elevated concentrations of oxygen.

Authors:  M J Evans; J D Hackney
Journal:  Aerosp Med       Date:  1972-06

8.  Some effects of binding agents on the x-irradiation of DNA.

Authors:  P E Brown
Journal:  Radiat Res       Date:  1968-04       Impact factor: 2.841

9.  Pharmacologic agents released in ultraviolet inflammation studied by continuous skin pefusion.

Authors:  M W Greaves; J Sondergaard
Journal:  J Invest Dermatol       Date:  1970-05       Impact factor: 8.551

10.  Polyamines. (1) Enhanced s-adenosyl-L-methionine decarboxylase in rapid growth systems, and (2) the relationships between polyamine concentration and RNA accumulation.

Authors:  D H Russell; J P Lombardini
Journal:  Biochim Biophys Acta       Date:  1971-06-30
View more
  4 in total

1.  Spermine-DNA interactions: a theoretical study.

Authors:  B G Feuerstein; N Pattabiraman; L J Marton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Purification and partial characterization of human polyamine synthases.

Authors:  E O Kajander; L I Kauppinen; R L Pajula; K Karkola; T O Eloranta
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

3.  Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylase.

Authors:  M A Pfaller; T Gerarden; J Riley
Journal:  Mycopathologia       Date:  1987-04       Impact factor: 2.574

4.  Decarboxylation of alpha-difluoromethylornithine by ornithine decarboxylase.

Authors:  A E Pegg; K A McGovern; L Wiest
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.